dokumendiregister.ee
OtsingAsutusedMCP
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumine

Sotsiaalministeerium · 1. aprill 2026
Viit
1.4-2/916-1
Registreeritud
1. aprill 2026
Dokumendi liik
Sissetulev kiri
Adressaat
Latvian Rare Disease Alliance
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2026
Vastutaja
Mari Amos (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Tervishoiukorralduse osakond)
Lahendamise tähtaeg
16. aprill 2026

Failid

  • 📎2026.03.31 Estonia on the right to choose medicines scan.PDF819 KB
  • 📎E-kiri.eml1182 KB

Sisu (failidest)

Saatja: "Reto slimību alianse" <[email protected]> Saaja: "Karmen Joller - SOM" <[email protected]>, "Info - SOM" <[email protected]> Teema: Request for information and experience sharing on medicine reimbursement and patient choice Kuupäev: 2026-03-31 18:24 Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Dear Ms Joller, During a recent conference in Latvia, I had the pleasure of meeting you and expressing my sincere appreciation for your dedication and passion in advocating for patients’ interests. I also mentioned that Latvia would greatly benefit from having such strong and committed leadership within its Ministry of Health. At this time, I would kindly like to ask for your advice and for the opportunity to learn from your experience regarding the pharmaceutical reimbursement system and patients’ rights to choose their therapy. On behalf of the Latvian Rare Disease Alliance, we are sending you this letter with a kind request to provide information and share your country’s experience regarding the pharmaceutical reimbursement system and patients’ rights to choose their therapy. Your insights and expertise would be extremely valuable for us, as they will help inform and support the policy-making process in Latvia aimed at improving patient access and choice in treatment. Please find attached the formal letter with detailed questions and context. We would greatly appreciate your response at your earliest convenience. Thank you very much for your time and support. Kind regards, Juris Beikmanis Chairman of the Board Latvian Rare Disease Alliance www.retasslimibas.lv Email: [email protected]
Allikas: Sotsiaalministeerium dokumendiregister →